Business Context and Reporting Period
Company: NeOnc Technologies Holdings, Inc. (NTHI)
Filing Type: Form 8-K (Current Report)
Date of Report: August 13, 2025
Reporting Period: The filing addresses a material error discovered in the Form 10-Q for the quarter ended March 31, 2025.
Key Financial Metrics
This filing does not report current revenue, profit, cash flow, or liquidity metrics. It specifically addresses a correction to non-cash share-based compensation expense.
- Item Affected: Non-cash share-based compensation expense.
- Instrument: 1,486,667 Restricted Stock Units (RSUs) issued on January 4, 2024.
- Error Description: The March 31, 2025 Form 10-Q incorrectly assumed these RSUs were fully vested as of March 31, 2025, leading to an overstatement of expense.
- Corrected Basis: The RSUs vest over 22 months; only 15 months of vesting had occurred as of March 31, 2025.
Material Changes Versus Prior Period
The filing identifies a material misstatement in the previously issued financial statements for the quarter ended March 31, 2025. The prior report overstated expenses due to an incorrect vesting calculation. Consequently, the Company has determined that the unaudited consolidated financial statements for that period should no longer be relied upon.
Guidance, Outlook, and Management Commentary
Management Action: Following discussions with the Audit Committee, management concluded that the financial statements for the quarter ended March 31, 2025, must be restated.
Restatement Status: The restated financial statements are presented in their entirety in the Company's Form 10-Q for the quarter ended June 30, 2025.
Risks and Contingencies: The filing highlights the risk of reliance on previously issued financial data which contained calculation errors regarding equity compensation.
Investor Verification Checklist
- Verify the restated financial figures in the Form 10-Q for the quarter ended June 30, 2025.
- Confirm the corrected non-cash share-based compensation expense calculation for the 1,486,667 RSUs.
- Review the impact of the restatement on net income and earnings per share for the quarter ended March 31, 2025.
- Assess any potential implications for internal controls over financial reporting related to equity compensation accounting.